OrthoPediatrics Corp. (KIDS)
Automate Your Wheel Strategy on KIDS
With Tiblio's Option Bot, you can configure your own wheel strategy including KIDS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol KIDS
- Rev/Share 9.71
- Book/Share 14.9149
- PB 1.1284
- Debt/Equity 0.1381
- CurrentRatio 7.3981
- ROIC -0.0694
- MktCap 422051363.0
- FreeCF/Share -1.2568
- PFCF -14.3384
- PE -8.6412
- Debt/Assets 0.0977
- DivYield 0
- ROE -0.1297
- Rating B-
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 5
- P/B Score 4
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | KIDS | Lake Street | -- | Buy | -- | $37 | April 7, 2025 |
News
Wall Street Analysts Believe OrthoPediatrics (KIDS) Could Rally 41.92%: Here's is How to Trade
Published: November 10, 2025 by: Zacks Investment Research
Sentiment: Positive
The consensus price target hints at a 41.9% upside potential for OrthoPediatrics (KIDS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Read More
OrthoPediatrics Corp. (KIDS) Q3 2025 Earnings Call Transcript
Published: October 28, 2025 by: Seeking Alpha
Sentiment: Neutral
OrthoPediatrics Corp. (NASDAQ:KIDS ) Q3 2025 Earnings Call October 28, 2025 4:30 PM EDT Company Participants David Bailey - President, CEO & Director Fred Hite - CFO, Principal Financial & Accounting Officer, COO and Director Conference Call Participants Philip Taylor - Gilmartin Group LLC David Turkaly - Citizens JMP Securities, LLC, Research Division Benjamin Haynor - Lake Street Capital Markets, LLC, Research Division Ravi Misra - Truist Securities, Inc., Research Division Presentation Operator Good afternoon, and welcome to the OrthoPediatrics Corporation Third Quarter 2025 Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes.
Read More
OrthoPediatrics (KIDS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Positive
The headline numbers for OrthoPediatrics (KIDS) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Read More
OrthoPediatrics (KIDS) Reports Q1 Loss, Tops Revenue Estimates
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Negative
OrthoPediatrics (KIDS) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to loss of $0.30 per share a year ago.
Read More
OrthoPediatrics Corp. (KIDS) Q4 2024 Earnings Call Transcript
Published: March 04, 2025 by: Seeking Alpha
Sentiment: Neutral
OrthoPediatrics Corp. (NASDAQ:KIDS ) Q4 2024 Earnings Conference Call March 4, 2025 4:30 PM ET Company Participants Trip Taylor - Gilmartin Group, IR David Bailey - President and CEO Fred Hite - Chief Operating and Financial Officer Conference Call Participants Ryan Zimmerman - BTIG Rick Wise - Stifel Matthew O'Brien - Piper Sandler Joseph Conway - Needham & Company Operator Hello. And welcome to OrthoPediatrics Corporation's Fourth Quarter and Full Year 2024 Earnings Conference Call.
Read More
Compared to Estimates, OrthoPediatrics (KIDS) Q4 Earnings: A Look at Key Metrics
Published: March 04, 2025 by: Zacks Investment Research
Sentiment: Neutral
While the top- and bottom-line numbers for OrthoPediatrics (KIDS) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read More
OrthoPediatrics (KIDS) Reports Q4 Loss, Misses Revenue Estimates
Published: March 04, 2025 by: Zacks Investment Research
Sentiment: Negative
OrthoPediatrics (KIDS) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to loss of $0.23 per share a year ago.
Read More
About OrthoPediatrics Corp. (KIDS)
- IPO Date 2017-10-13
- Website https://www.orthopediatrics.com
- Industry Medical - Devices
- CEO David R. Bailey
- Employees 562